Elsevier

Annals of Oncology

Volume 31, Supplement 4, September 2020, Page S1191
Annals of Oncology

Oesophagogastric cancer
LBA6_PR Nivolumab (nivo) plus chemotherapy (chemo) versus chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer (GC/GEJC)/esophageal adenocarcinoma (EAC): First results of the CheckMate 649 study

https://doi.org/10.1016/j.annonc.2020.08.2296Get rights and content
Under an Elsevier user license
open archive

Cited by (0)